Medtronic Acquires Nano Surface Technology Assets from Nanovis

Medtronic to Acquire Scientia Vascular

March 10, 2026

Medical Devices

Medtronic entered into a definitive agreement to acquire Scientia Vascular in a $550 million deal, with customary adjustments and potential earn-out/milestone payments. The acquisition combines Scientia’s neurovascular access devices (guidewires and catheters) with Medtronic’s existing neurovascular therapeutic portfolio to support faster and more reliable treatment for complex stroke cases.

Boston Scientific Acquires Valencia Technologies

January 12, 2026

Medical Devices

Boston Scientific acquired Valencia Technologies to advance its urology and pelvic health portfolio, adding Valencia’s implantable tibial nerve stimulation technology. The deal is expected to close in the first half of 2026, with financial terms undisclosed.

NanoVibronix, Inc. Acquires ENvue Medical Holdings Corp.

February 14, 2025

Medical Devices

NanoVibronix, Inc. (NASDAQ: NAOV) completed a stock-for-stock acquisition of ENvue Medical Holdings Corp., adding ENvue's FDA 510(k)-cleared electromagnetic navigation enteral feeding system to NanoVibronix's medical device portfolio. The transaction, which issued NanoVibronix common and Series X preferred shares to ENvue holders and was accompanied by a $500,000 senior convertible debenture private placement, is intended to expand commercial reach, product capabilities and operational efficiencies in enteral feeding and guided medical navigation.

Second Sight Medical Products Merges With Nano Precision Medical to Form Vivani Medical

August 30, 2022

Healthcare Services

Second Sight Medical Products entered into a definitive all-stock agreement to acquire full ownership of privately held Nano Precision Medical, with NPM surviving the merger. The combined company (later renamed Vivani Medical) will focus on development of drug and device medical implants for chronic diseases, including NPM-119 for Type 2 diabetes and continued exploration of Second Sight’s Orion visual prosthesis.

Medtronic to Acquire Intersect ENT for $1.1 Billion

August 7, 2021

Medical Devices

Medtronic plc entered into a definitive agreement to buy all outstanding shares of Intersect ENT in an all-cash transaction valued at approximately $1.1 billion (at $28.25 per share). The acquisition aims to expand Medtronic’s ENT product portfolio by combining Intersect ENT’s PROPEL and SINUVA sinus implants with Medtronic’s navigation and related tissue health offerings.

Danaher Acquires Precision NanoSystems

June 1, 2021

Biotechnology

Danaher Corporation has acquired Vancouver-based Precision NanoSystems (PNI), a developer of lipid nanoparticle delivery technologies and microfluidic manufacturing platforms for genetic medicines. PNI will join Danaher's Life Sciences platform to expand its capabilities in mRNA and genetic-medicine development and complement existing portfolio companies such as Cytiva and Pall.